Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02943109 · ClinicalTrials.gov registry record · NA

High Tech and High Touch (HT2): Transforming Patient Engagement Through Portal Technology at the Bedside

A NA study of Physician-Patient Relations and Electronic Health Records, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
3,782
Enrollment target
1
Study location

NCT02943109 is a NA study of Physician-Patient Relations and Electronic Health Records that has completed, run by Ohio State University. The registered enrollment target is 3,782 participants, above the 811-participant average among 5 other Physician-Patient Relations trials with a reported enrollment target (366% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02943109, a NA study of Physician-Patient Relations and Electronic Health Records, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
3,782 participants
Enrollment target
1
Study location

Study Summary

A large-scale randomized control trial (RCT) of the impact and use of an inpatient tablet-based patient portal embedded in a larger mixed methods study to examine changes in patient experiences and outcomes, and subsequent ambulatory patient portal usage.

Interventions

  • OTHER High Touch
  • OTHER Low Touch
  • OTHER High Tech
  • OTHER Low Tech

Study Locations (1)

Ohio

  • Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 3,782 participants
Start Date 2016-12
Est. Completion 2020-04
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT02943109

The ClinicalTrials.gov registry entry for NCT02943109 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,782 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 811-participant average among 5 other Physician-Patient Relations trials with a reported enrollment target (366% higher). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Physician-Patient Relations appearing as the primary indexed condition, and to 4 interventions - of which High Touch is the first listed.

NCT02943109 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02943109 about?

NCT02943109 is a clinical study titled "High Tech and High Touch (HT2): Transforming Patient Engagement Through Portal Technology at the Bedside". A large-scale randomized control trial (RCT) of the impact and use of an inpatient tablet-based patient portal embedded in a larger mixed methods study to examine changes in patient experiences and outcomes, and subsequent ambulatory patient portal usage.

What is the current status of trial NCT02943109?

This trial is currently completed. It is a NA study. The enrollment target is 3,782 participants. The study started on 2016-12. Estimated completion is 2020-04.

What conditions does trial NCT02943109 study?

This clinical trial studies the following conditions: Physician-Patient Relations, Electronic Health Records, Inpatient Facility Diagnoses, Outpatient.

What interventions are being tested in trial NCT02943109?

The interventions under investigation include: High Touch (OTHER), Low Touch (OTHER), High Tech (OTHER), Low Tech (OTHER).

Who is sponsoring clinical trial NCT02943109?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02943109 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Physician-Patient Relations

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.